Growth and puberty in children with HIV infection

Area of Science:

• Pediatric Endocrinology
• Infectious Diseases
• Child Health

Background:

• Perinatal HIV infection is linked to endocrine dysfunction, manifesting as growth failure and pubertal delay in children.
• These growth and pubertal issues can be worsened by treatable conditions, necessitating comprehensive evaluation.
• The association between HIV and pediatric endocrine dysfunction requires further investigation, especially concerning highly active antiretroviral therapy (HAART).

Purpose of the Study:

• To highlight the clinical features of endocrine dysfunction in children with perinatal HIV infection.
• To emphasize the importance of preventive, screening, and therapeutic strategies for managing growth and pubertal delays.
• To underscore the need for better understanding of the mechanisms underlying these dysfunctions for improved treatment.

Main Methods:

• Periodic growth evaluation in HIV-infected children with advanced disease, including hormone level assessments (e.g., GH, IGF-I, androgens).
• Monitoring for subclinical endocrine dysfunction and metabolic alterations.
• Review of potential contributing factors such as hypothalamic-pituitary axis dysregulation and drug reactions.

Main Results:

• Growth retardation and pubertal delay are common in advanced HIV infection, often linked to a proinflammatory state.
• Subclinical endocrine dysfunction may be present and requires specific evaluations.
• Highly active antiretroviral therapy may also contribute to endocrine issues affecting growth and puberty.

Conclusions:

• Children with perinatal HIV infection require vigilant monitoring for endocrine dysfunction, particularly growth and pubertal delays.
• Timely diagnosis and management of associated disorders can improve growth and pubertal outcomes.
• Further research into the mechanisms of HIV-related endocrine dysfunction is essential for optimizing care.